\-\ Texto\\:\\ \ \(0\)\
\-\ spontaneous\\,\\ yellow\\,\\ guiac\\ negative\\ nipple\\ discharge\\ bilaterally\ \(1\)\
\-\ none\ \(204\)\
\-\ a\\ ductogram\\ was\\ performed\\ on\\ the\\ left\\,\\ following\\ cannulation\\ of\\ an\\ orifice\\ at\\ 3\\:00\\.\\ \\ a\\ small\\,\\ circumscribed\\ filling\\ defect\\ was\\ apparent\\ approximately\\ 3\\ cm\\ from\\ the\\ nipple\\.\\ \\ the\\ ducts\\ were\\ normal\\ in\\ caliber\\ and\\ regular\\ in\\ contour\\.\ \(0\)\
\-\ \\	ductogram\\ of\\ the\\ right\\ breast\\ \\(not\\ shown\\)\\ demonstrated\\ duct\\ ectasia\\ but\\ no\\ other\\ abnormality\\.\\ \ \(0\)\
\-\ \\	follow\\ up\\ of\\ ductogram\\ on\\ the\\ left\\,\\ again\\ following\\ cannulation\\ at\\ 3\\:00\\,\\ performed\\ approximately\\ one\\ month\\ later\\ demonstrated\\ a\\ normal\\ caliber\\ ductal\\ system\\ with\\ no\\ filling\\ defects\\.\ \(0\)\
\-\ filling\\ defects\\ at\\ ductography\ \(1\)\
\-\ differential\\:\\ \\ \\(filling\\ defects\\ at\\ ductography\\)\ \(0\)\
\-\ 1\\.\\	papillary\\ lesion\\ \\(papilloma\\ or\\ papillomatosis\\)\ \(0\)\
\-\ 2\\.\\	papillary\\ carcinoma\\ or\\ dcis\ \(0\)\
\-\ 3\\.\\	debris\\ in\\ the\\ duct\\ lumen\ \(0\)\
\-\ 4\\.\\	hematoma\ \(0\)\
\-\ 5\\.\\	air\\ bubble\ \(0\)\
\-\ a\\ 38\\ year\\ old\\ woman\\ with\\ bilateral\\ spontaneous\\ nipple\\ discharge\\,\\ which\\ was\\ yellow\\ in\\ color\\ and\\ guiac\\ negative\\.\ \(1\)\
\-\ ductography\\ is\\ most\\ frequently\\ performed\\ in\\ the\\ evaluation\\ of\\ patients\\ with\\ unilateral\\,\\ spontaneous\\ nipple\\ discharge\\.\\ \\ the\\ most\\ common\\ cause\\ of\\ these\\ symptoms\\ is\\ a\\ papilloma\\,\\ but\\ papillary\\ carcinomas\\ are\\ indistinguishable\\ by\\ imaging\\.\\ \\ clear\\ or\\ sanguineous\\ discharge\\ is\\ more\\ frequently\\ associated\\ with\\ a\\ malignant\\ lesion\\.\\ \\ lesions\\ identified\\ at\\ ductography\\ are\\ treated\\ by\\ duct\\ excision\\.\ \(0\)\
\-\ \\	ductography\\ is\\ accomplished\\ by\\ expression\\ of\\ a\\ small\\ amount\\ of\\ discharge\\ from\\ the\\ affected\\ nipple\\ orifice\\.\\ \\ the\\ duct\\ is\\ then\\ cannulated\\ with\\ a\\ blunt\\,\\ 30\\-gauge\\ needle\\,\\ and\\ 0\\.2\\-0\\.3cc\\ of\\ water\\ soluble\\ contrast\\ is\\ injected\\.\\ \\ orthogonal\\ magnification\\ views\\ are\\ then\\ obtained\\.\\ \\ filling\\ defects\\ within\\ the\\ ductal\\ system\\ may\\ reflect\\ a\\ papilloma\\,\\ papillary\\ carcinoma\\,\\ or\\ intraductal\\ debris\\.\\ \\ air\\ bubbles\\ may\\ also\\ cause\\ filling\\ defects\\ and\\ efforts\\ should\\ be\\ made\\ to\\ clear\\ bubbles\\ from\\ the\\ syringe\\ and\\ tubing\\ prior\\ to\\ injection\\.\ \(0\)\
\-\ \\	papillomas\\ secrete\\ large\\ quantities\\ of\\ fluid\\.\\ \\ they\\ may\\ present\\ as\\ ductal\\ filling\\ defects\\ with\\ dilation\\ of\\ the\\ downstream\\ duct\\ \\(that\\ is\\,\\ the\\ portion\\ of\\ the\\ duct\\ closer\\ to\\ the\\ nipple\\)\\ because\\ of\\ hyper\\ secretion\\.\\ \\ alternatively\\,\\ a\\ papilloma\\ may\\ cause\\ complete\\ obstruction\\ of\\ the\\ duct\\ and\\ result\\ in\\ a\\ \\&\\#8220\\;cut\\ off\\&\\#8221\\;\\ appearance\\ on\\ ductography\\.\\ \\ findings\\ may\\ be\\ similar\\ for\\ carcinomas\\;\\ examination\\ of\\ the\\ tissues\\ adjacent\\ to\\ the\\ duct\\ may\\ yield\\ additional\\ evidence\\ of\\ malignancy\\.\ \(0\)\
\-\ reference\\:\\ \\ s\\.\\ horatio\\ slawson\\,\\ md\\ \\&\\#8226\\;\\ bradley\\ a\\.\\ johnson\\,\\ md\\ \\.\\ \\ ductography\\:\\ how\\ to\\ and\\ what\\ if\\ \\?\\ \\ radiographics\\ 2001\\;\\ 21\\:133\\&\\#8211\\;150\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ductography\\:\\ 0\\.4164199520249706\ \(0\)\
\-\ duct\\:\\ 0\\.28477116830298316\ \(0\)\
\-\ nipple\\:\\ 0\\.26234017416746125\ \(0\)\
\-\ filling\\:\\ 0\\.22416348297857389\ \(0\)\
\-\ defects\\:\\ 0\\.21390176194015167\ \(0\)\
\-\ ductogram\\:\\ 0\\.18957491944727953\ \(0\)\
\-\ discharge\\:\\ 0\\.18540495471955049\ \(0\)\
\-\ the\\:\\ 0\\.15677342815732515\ \(0\)\
\-\ papillary\\:\\ 0\\.15414276885776923\ \(0\)\
\-\ papilloma\\:\\ 0\\.15167346616854327\ \(0\)\
\-\ may\\:\\ 0\\.1248579435708794\ \(0\)\
\-\ cannulation\\:\\ 0\\.12221235197971536\ \(0\)\
\-\ of\\:\\ 0\\.12138620769813863\ \(0\)\
\-\ guiac\\:\\ 0\\.11409882253940819\ \(0\)\
\-\ ductal\\:\\ 0\\.10917020621271759\ \(0\)\
\-\ spontaneous\\:\\ 0\\.10794712793249966\ \(0\)\
\-\ orifice\\:\\ 0\\.10211331196982913\ \(0\)\
\-\ bubbles\\:\\ 0\\.09887808914010536\ \(0\)\
\-\ carcinomas\\:\\ 0\\.09252409705995332\ \(0\)\
\-\ yellow\\:\\ 0\\.09076455969979817\ \(0\)\
\-\ debris\\:\\ 0\\.0877800357851051\ \(0\)\
\-\ caliber\\:\\ 0\\.08680224561366391\ \(0\)\
\-\ cause\\:\\ 0\\.08451282028590568\ \(0\)\
\-\ is\\:\\ 0\\.07927178567281623\ \(0\)\
\-\ at\\:\\ 0\\.07809597064262518\ \(0\)\
\-\ md\\:\\ 0\\.07539956249654545\ \(0\)\
\-\ performed\\:\\ 0\\.07339202977258769\ \(0\)\
\-\ frequently\\:\\ 0\\.06810870799179923\ \(0\)\
\-\ horatio\\:\\ 0\\.06613093599232925\ \(0\)\
\-\ slawson\\:\\ 0\\.06613093599232925\ \(0\)\
\-\ 8226\\:\\ 0\\.06613093599232925\ \(0\)\
\-\ sanguineous\\:\\ 0\\.06319163981575984\ \(0\)\
\-\ syringe\\:\\ 0\\.06319163981575984\ \(0\)\
\-\ system\\:\\ 0\\.06309461297321393\ \(0\)\
\-\ in\\:\\ 0\\.06172229327150181\ \(0\)\
\-\ downstream\\:\\ 0\\.06110617598985768\ \(0\)\
\-\ clear\\:\\ 0\\.059958019045440465\ \(0\)\
\-\ and\\:\\ 0\\.05981426916124254\ \(0\)\
\-\ cannulated\\:\\ 0\\.0594885645749958\ \(0\)\
\-\ quantities\\:\\ 0\\.0594885645749958\ \(0\)\
\-\ bradley\\:\\ 0\\.0594885645749958\ \(0\)\
\-\ then\\:\\ 0\\.05854471987109508\ \(0\)\
\-\ secrete\\:\\ 0\\.05816687981328828\ \(0\)\
\-\ or\\:\\ 0\\.057542572396420605\ \(0\)\
\-\ papillomas\\:\\ 0\\.057049411269704094\ \(0\)\
\-\ johnson\\:\\ 0\\.057049411269704094\ \(0\)\
\-\ 8211\\:\\ 0\\.057049411269704094\ \(0\)\
\-\ tubing\\:\\ 0\\.05608141598738613\ \(0\)\
\-\ orthogonal\\:\\ 0\\.05446380457252424\ \(0\)\
\-\ 8220\\:\\ 0\\.05446380457252424\ \(0\)\
\-\ 8221\\:\\ 0\\.05446380457252424\ \(0\)\
\-\ air\\:\\ 0\\.05409593027140234\ \(0\)\
\-\ expression\\:\\ 0\\.05377288236618667\ \(0\)\
\-\ efforts\\:\\ 0\\.05377288236618667\ \(0\)\
\-\ soluble\\:\\ 0\\.05314211981081672\ \(0\)\
\-\ yield\\:\\ 0\\.05314211981081672\ \(0\)\
\-\ approximately\\:\\ 0\\.052771243202350215\ \(0\)\
\-\ by\\:\\ 0\\.05268144074433984\ \(0\)\
\-\ reflect\\:\\ 0\\.05256187450752831\ \(0\)\
\-\ secretion\\:\\ 0\\.05256187450752831\ \(0\)\
\-\ indistinguishable\\:\\ 0\\.05202465126723253\ \(0\)\
\-\ to\\:\\ 0\\.051689660796304625\ \(0\)\
\-\ magnification\\:\\ 0\\.05152450839595483\ \(0\)\
\-\ alternatively\\:\\ 0\\.05152450839595483\ \(0\)\
\-\ negative\\:\\ 0\\.05120154730349764\ \(0\)\
\-\ papillomatosis\\:\\ 0\\.051056655984914566\ \(0\)\
\-\ dcis\\:\\ 0\\.051056655984914566\ \(0\)\
\-\ demonstrated\\:\\ 0\\.05082771904821017\ \(0\)\
\-\ closer\\:\\ 0\\.05061717619849734\ \(0\)\
\-\ following\\:\\ 0\\.04961460263911892\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04946985874799289\ \(0\)\
\-\ from\\:\\ 0\\.049269847573488734\ \(0\)\
\-\ with\\:\\ 0\\.048583494371325406\ \(0\)\
\-\ intraductal\\:\\ 0\\.04811735980834516\ \(0\)\
\-\ are\\:\\ 0\\.04707367092433286\ \(0\)\
\-\ ectasia\\:\\ 0\\.04626204852997666\ \(0\)\
\-\ bubble\\:\\ 0\\.0458088261871457\ \(0\)\
\-\ injected\\:\\ 0\\.045178063631775754\ \(0\)\
\-\ cut\\:\\ 0\\.045178063631775754\ \(0\)\
\-\ 150\\:\\ 0\\.044979443088447604\ \(0\)\
\-\ hyper\\:\\ 0\\.044786119729379445\ \(0\)\
\-\ accomplished\\:\\ 0\\.04423528297083453\ \(0\)\
\-\ blunt\\:\\ 0\\.04389001789255255\ \(0\)\
\-\ how\\:\\ 0\\.043723362361243544\ \(0\)\
\-\ was\\:\\ 0\\.04323480019853979\ \(0\)\
\-\ most\\:\\ 0\\.04304172173228952\ \(0\)\
\-\ small\\:\\ 0\\.04266156380538853\ \(0\)\
\-\ ducts\\:\\ 0\\.04265312001945637\ \(0\)\
\-\ radiographics\\:\\ 0\\.04172074739524523\ \(0\)\
\-\ water\\:\\ 0\\.041355164235850145\ \(0\)\
\-\ but\\:\\ 0\\.04089731019615161\ \(0\)\
\-\ reference\\:\\ 0\\.04046182663026254\ \(0\)\
\-\ what\\:\\ 0\\.039761359726907884\ \(0\)\
\-\ lesion\\:\\ 0\\.03965018874750103\ \(0\)\
\-\ 2001\\:\\ 0\\.03903583508572\ \(0\)\
\-\ needle\\:\\ 0\\.038376362804360395\ \(0\)\
\-\ unilateral\\:\\ 0\\.037844770008104725\ \(0\)\
\-\ on\\:\\ 0\\.037467089904836035\ \(0\)\
\-\ color\\:\\ 0\\.03728144232354983\ \(0\)\
\-\ contour\\:\\ 0\\.03721400745273478\ \(0\)\
\-\ again\\:\\ 0\\.03688593353475898\ \(0\)\
\-\ lumen\\:\\ 0\\.03682206355033848\ \(0\)\
\-\ 38\\:\\ 0\\.03669598739277367\ \(0\)\
\-\ dilation\\:\\ 0\\.03639006873757253\ \(0\)\
\-\ injection\\:\\ 0\\.035982375977499884\ \(0\)\
\-\ regular\\:\\ 0\\.03570459500675429\ \(0\)\
\-\ apparent\\:\\ 0\\.034594917110171645\ \(0\)\
\-\ off\\:\\ 0\\.034548298323544224\ \(0\)\
\-\ affected\\:\\ 0\\.03401107508324844\ \(0\)\
\-\ normal\\:\\ 0\\.03376753237396435\ \(0\)\
\-\ be\\:\\ 0\\.033549749919053996\ \(0\)\
\-\ amount\\:\\ 0\\.03308093469811182\ \(0\)\
\-\ views\\:\\ 0\\.03263922267262008\ \(0\)\
\-\ excision\\:\\ 0\\.03260360001451325\ \(0\)\
\-\ tissues\\:\\ 0\\.03260360001451325\ \(0\)\
\-\ shown\\:\\ 0\\.032056230941438536\ \(0\)\
\-\ additional\\:\\ 0\\.032056230941438536\ \(0\)\
\-\ circumscribed\\:\\ 0\\.03202335471122484\ \(0\)\
\-\ made\\:\\ 0\\.031893320797108854\ \(0\)\
\-\ similar\\:\\ 0\\.031516654447969285\ \(0\)\
\-\ result\\:\\ 0\\.030957615975028326\ \(0\)\
\-\ malignancy\\:\\ 0\\.030957615975028326\ \(0\)\
\-\ defect\\:\\ 0\\.030333936171894716\ \(0\)\
\-\ abnormality\\:\\ 0\\.030078656402193864\ \(0\)\
\-\ breast\\:\\ 0\\.03002866174653956\ \(0\)\
\-\ later\\:\\ 0\\.0295935794102646\ \(0\)\
\-\ portion\\:\\ 0\\.029570157107700085\ \(0\)\
\-\ they\\:\\ 0\\.029546810239412937\ \(0\)\
\-\ malignant\\:\\ 0\\.029477217420099455\ \(0\)\
\-\ identified\\:\\ 0\\.029317386144508864\ \(0\)\
\-\ obtained\\:\\ 0\\.029249951273693814\ \(0\)\
\-\ complete\\:\\ 0\\.02898631508077688\ \(0\)\
\-\ obstruction\\:\\ 0\\.028964772133756735\ \(0\)\
\-\ hematoma\\:\\ 0\\.028943293017784255\ \(0\)\
\-\ because\\:\\ 0\\.028900524773749207\ \(0\)\
\-\ left\\:\\ 0\\.028212174707686496\ \(0\)\
\-\ bilaterally\\:\\ 0\\.02757884001204169\ \(0\)\
\-\ should\\:\\ 0\\.026982212337177198\ \(0\)\
\-\ no\\:\\ 0\\.02689443456048542\ \(0\)\
\-\ differential\\:\\ 0\\.02686856079463729\ \(0\)\
\-\ adjacent\\:\\ 0\\.026804408195985556\ \(0\)\
\-\ examination\\:\\ 0\\.026461371468457503\ \(0\)\
\-\ treated\\:\\ 0\\.025751092251053105\ \(0\)\
\-\ evaluation\\:\\ 0\\.025218802114953972\ \(0\)\
\-\ month\\:\\ 0\\.025154932130533467\ \(0\)\
\-\ appearance\\:\\ 0\\.024929550360623286\ \(0\)\
\-\ if\\:\\ 0\\.02402657072789411\ \(0\)\
\-\ fluid\\:\\ 0\\.023875764771277647\ \(0\)\
\-\ cm\\:\\ 0\\.02374895343838264\ \(0\)\
\-\ lesions\\:\\ 0\\.02374895343838264\ \(0\)\
\-\ one\\:\\ 0\\.023675991824109982\ \(0\)\
\-\ evidence\\:\\ 0\\.023471487533649103\ \(0\)\
\-\ common\\:\\ 0\\.02345135086420885\ \(0\)\
\-\ these\\:\\ 0\\.02335149809624908\ \(0\)\
\-\ patients\\:\\ 0\\.023262791663699475\ \(0\)\
\-\ prior\\:\\ 0\\.023136546607908003\ \(0\)\
\-\ more\\:\\ 0\\.02270670030641311\ \(0\)\
\-\ symptoms\\:\\ 0\\.02262550124085804\ \(0\)\
\-\ none\\:\\ 0\\.02259863575116995\ \(0\)\
\-\ follow\\:\\ 0\\.022292347742163078\ \(0\)\
\-\ bilateral\\:\\ 0\\.022224119508281865\ \(0\)\
\-\ associated\\:\\ 0\\.02179563319742704\ \(0\)\
\-\ imaging\\:\\ 0\\.021731903588408822\ \(0\)\
\-\ woman\\:\\ 0\\.02153628469395741\ \(0\)\
\-\ other\\:\\ 0\\.02147478531058302\ \(0\)\
\-\ were\\:\\ 0\\.02131578873015784\ \(0\)\
\-\ present\\:\\ 0\\.021219081752224783\ \(0\)\
\-\ large\\:\\ 0\\.020719431537601404\ \(0\)\
\-\ up\\:\\ 0\\.02045530268803015\ \(0\)\
\-\ findings\\:\\ 0\\.020408897066038108\ \(0\)\
\-\ contrast\\:\\ 0\\.020092118516599294\ \(0\)\
\-\ also\\:\\ 0\\.019450820868055257\ \(0\)\
\-\ within\\:\\ 0\\.019045480714940388\ \(0\)\
\-\ which\\:\\ 0\\.0188031901820944\ \(0\)\
\-\ that\\:\\ 0\\.017945240473666205\ \(0\)\
\-\ as\\:\\ 0\\.016612587510501636\ \(0\)\
\-\ not\\:\\ 0\\.0163248070787503\ \(0\)\
\-\ an\\:\\ 0\\.015812886469159314\ \(0\)\
\-\ right\\:\\ 0\\.013709916727149676\ \(0\)\
\-\ year\\:\\ 0\\.012743888751281133\ \(0\)\
\-\ for\\:\\ 0\\.012533490066778655\ \(0\)\
\-\ old\\:\\ 0\\.012238544607797146\ \(0\)\
